These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 17324745

  • 1. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
    Hiltunen TP, Suonsyrjä T, Hannila-Handelberg T, Paavonen KJ, Miettinen HE, Strandberg T, Tikkanen I, Tilvis R, Pentikäinen PJ, Virolainen J, Kontula K.
    Am J Hypertens; 2007 Mar; 20(3):311-8. PubMed ID: 17324745
    [Abstract] [Full Text] [Related]

  • 2. Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.
    Suonsyrjä T, Hannila-Handelberg T, Paavonen KJ, Miettinen HE, Donner K, Strandberg T, Tikkanen I, Tilvis R, Pentikäinen PJ, Kontula K, Hiltunen TP.
    J Hypertens; 2008 Jun; 26(6):1250-6. PubMed ID: 18475165
    [Abstract] [Full Text] [Related]

  • 3. Pharmacoepigenetics of hypertension: genome-wide methylation analysis of responsiveness to four classes of antihypertensive drugs using a double-blind crossover study design.
    Nuotio ML, Sánez Tähtisalo H, Lahtinen A, Donner K, Fyhrquist F, Perola M, Kontula KK, Hiltunen TP.
    Epigenetics; 2022 Nov; 17(11):1432-1445. PubMed ID: 35213289
    [Abstract] [Full Text] [Related]

  • 4. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension.
    Benetos A, Consoli S, Safavian A, Dubanchet A, Safar M.
    Am Heart J; 2000 Oct; 140(4):E11. PubMed ID: 11011336
    [Abstract] [Full Text] [Related]

  • 5. Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.
    Hiltunen TP, Donner KM, Sarin AP, Saarela J, Ripatti S, Chapman AB, Gums JG, Gong Y, Cooper-DeHoff RM, Frau F, Glorioso V, Zaninello R, Salvi E, Glorioso N, Boerwinkle E, Turner ST, Johnson JA, Kontula KK.
    J Am Heart Assoc; 2015 Jan 26; 4(1):e001521. PubMed ID: 25622599
    [Abstract] [Full Text] [Related]

  • 6. Clinical and molecular approaches to individualize antihypertensive drug therapy.
    Hiltunen TP, Kontula K.
    Ann Med; 2012 Jun 26; 44 Suppl 1():S23-9. PubMed ID: 22713145
    [Abstract] [Full Text] [Related]

  • 7. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
    Oparil S, Chrysant SG, Melino M, Lee J, Karki S, Heyrman R.
    J Hum Hypertens; 2010 Dec 26; 24(12):831-8. PubMed ID: 20200547
    [Abstract] [Full Text] [Related]

  • 8. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L, Wang W, Zhao Y, Zhang Y, Deng Q, Liu M, Sun H, Wang J, Liu L.
    Am J Cardiovasc Drugs; 2012 Apr 01; 12(2):137-42. PubMed ID: 22329591
    [Abstract] [Full Text] [Related]

  • 9. STK39 variation predicts the ambulatory blood pressure response to losartan in hypertensive men.
    Donner KM, Hiltunen TP, Hannila-Handelberg T, Suonsyrjä T, Kontula K.
    Hypertens Res; 2012 Jan 01; 35(1):107-14. PubMed ID: 21993215
    [Abstract] [Full Text] [Related]

  • 10. Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.
    Radchenko GD, Sirenko YM, Kushnir SM, Torbas OO, Dobrokhod AS.
    Vasc Health Risk Manag; 2013 Jan 01; 9():535-49. PubMed ID: 24109189
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
    Hong BK, Park CG, Kim KS, Yoon MH, Yoon HJ, Yoon JH, Yang JY, Choi YJ, Cho SY.
    Am J Cardiovasc Drugs; 2012 Jun 01; 12(3):189-95. PubMed ID: 22462558
    [Abstract] [Full Text] [Related]

  • 12. Short-term electrophysiological effects of losartan, bisoprolol, amlodipine, and hydrochlorothiazide in hypertensive men.
    Porthan K, Viitasalo M, Hiltunen TP, Vaananen H, Dabek J, Suonsyrja T, Hannila-Handelberg T, Virolainen J, Nieminen MS, Toivonen L, Kontula K, Oikarinen L.
    Ann Med; 2009 Jun 01; 41(1):29-37. PubMed ID: 18608135
    [Abstract] [Full Text] [Related]

  • 13. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH, Park SJ, Kim EJ, Kim SJ, Cho HJ, Song JM, Shin J, Park JJ, Shin JH, Han KR, Choi DJ.
    Trials; 2018 Jun 20; 19(1):324. PubMed ID: 29925421
    [Abstract] [Full Text] [Related]

  • 14. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea.
    Kraiczi H, Hedner J, Peker Y, Grote L.
    Am J Respir Crit Care Med; 2000 May 20; 161(5):1423-8. PubMed ID: 10806134
    [Abstract] [Full Text] [Related]

  • 15. Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.
    Ando K, Isshiki M, Takahashi K, ONgoing Evaluation of depressor effect And Safety of combination therapy with Telmisartan and low-dose hydrochlorothiazide (ONEAST) Study Group.
    Hypertens Res; 2009 Sep 20; 32(9):748-52. PubMed ID: 19590506
    [Abstract] [Full Text] [Related]

  • 16. The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension.
    Phillips RA, Kloner RA, Grimm RH, Weinberger M.
    J Clin Hypertens (Greenwich); 2003 Sep 20; 5(1):17-23. PubMed ID: 12556649
    [Abstract] [Full Text] [Related]

  • 17. Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice.
    Bramlage P, Fronk EM, Wolf WP, Smolnik R, Sutton G, Schmieder RE.
    Vasc Health Risk Manag; 2015 Sep 20; 11():1-8. PubMed ID: 25565857
    [Abstract] [Full Text] [Related]

  • 18. Comparison of 24-Hour Ambulatory Central Blood Pressure Reduction Efficacy Between Fixed Amlodipine or Up-Titrated Hydrochlorothiazide Plus Losartan: The K-Central Study.
    Cho EJ, Lee HY, Sung KC, Park S, Sohn IS, Park CG, Choi DJ, Ha JW, Ahn YK, Shin J, Hong SJ, Kim SK, Chung WJ, Yoo BS, Hong TJ, Youn HJ, Cho MC, Chae SC, Kim YJ, Kim CJ.
    Am J Hypertens; 2019 Sep 24; 32(10):992-1002. PubMed ID: 31099387
    [Abstract] [Full Text] [Related]

  • 19. A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide.
    Segura J, Ruilope LM.
    Vasc Health Risk Manag; 2013 Sep 24; 9():521-8. PubMed ID: 24082785
    [Abstract] [Full Text] [Related]

  • 20. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho B, Ueng KC, DiTommaso S, Shete A.
    Vasc Health Risk Manag; 2015 Sep 24; 11():71-8. PubMed ID: 25653536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.